Syringomyelia & Chiari-like Malformation in Cavaliers: Symptoms, Diagnosis & Management

Overview: why Cavaliers are uniquely affected

[Cavalier King Charles](https://seniorpet.org/knowledge/breed/cavalier-king-charles-spaniel "Senior Cavalier King Charles Spaniel Health Guide") Spaniels (CKCS) are one of the few dog breeds at very high risk for Chiari‑like malformation (CM) and its painful complication, syringomyelia (SM). CM in this breed is not an incidental anatomic variant — it is a developmental mismatch between the size of the skull base and the brain that commonly leads to cerebrospinal fluid (CSF) flow obstruction and syrinx (fluid‑filled cavity) formation in the spinal cord. Because these changes often begin early in life and are progressive, early recognition, accurate diagnosis, and an individualized management plan are critical to preserve [quality of life](https://seniorpet.org/knowledge/[siamese](https://seniorpet.org/knowledge/breed/siamese "Senior Siamese Cat Health Guide")-cat-quality-of-life "Quality of Life Assessment") for affected Cavaliers.

Key Statistics & Research Data

• CM is extremely common in CKCS—published MRI screening series report Chiari‑like malformation in more than 90% of routine MRI scans in the breed (BVA/KC screening data; Rusbridge and colleagues).
• Syringomyelia prevalence in screened CKCS populations is commonly reported around 30–50%; one widely quoted figure for screened cohorts is ~41% (BVA/KC; Rusbridge et al.).
• Onset: clinical signs often appear between 6 months and 3 years of age, but imaging evidence of CM/SM can be present earlier (Rusbridge 2000s reviews).
• Phantom scratching (scratching at the air beside the neck/shoulder without skin contact) is highly suggestive — often described as pathognomonic for SM in CKCS (Rusbridge et al.; clinical series).
• MRI is the gold standard diagnostic test for CM/SM; radiographs and CT cannot reliably show posterior fossa overcrowding or a syrinx (Garosi, Rusbridge).
• Surgical decompression (foramen magnum decompression [FMD] ± cranioplasty/duroplasty) can improve clinical signs in a majority of carefully selected CKCS; reported improvement rates vary, commonly ~60–80% subjective improvement in case series, with variable syrinx reduction on follow‑up MRI (Rusbridge; Garosi).
• Primary secretory otitis media (PSOM, “glue ear”) occurs commonly in CKCS and can mimic or coexist with CM/SM — reported prevalence of PSOM in CKCS ranges from ~20–40% in some cohorts (breed screening studies).

(References: Rusbridge R. and colleagues; British Veterinary Association/Kennel Club CM/SM screening scheme; Garosi L. reviews — see veterinary neurology literature for primary sources.)

Note: prevalence figures vary by study population (clinical vs screening cohorts), MRI protocols, and age at imaging. Refer to your neurologist for interpretation related to your individual dog.

Pathophysiology in Cavaliers (breed‑specific)

Cavalier skull conformation predisposes them to CM and SM through a distinctive series of anatomic and developmental changes:

• Occipital bone hypoplasia and small caudal cranial fossa: In CKCS the bones forming the back of the skull (occipital and surrounding structures) are often relatively small. The caudal cranial fossa — the compartment that houses the cerebellum and brainstem — is too small to accommodate the developing cerebellum, producing overcrowding.
• Cerebellar crowding and herniation: The overcrowding forces some cerebellar tissue caudally through the foramen magnum (the opening at the base of the skull). This is analogous to Chiari I malformation in people and is why the disease is called Chiari‑like.
• CSF flow obstruction and turbulent flow: As the cerebellum and sometimes cerebellar tonsils obstruct normal CSF movement between the cranial vault and the spinal subarachnoid space, CSF pulsations become abnormal, producing high‑pressure jets and turbulent flow at the craniocervical junction.
• Syrinx formation: Repeated CSF flow disturbances and pressure differentials drive fluid into the central canal or parenchyma of the cervical spinal cord, forming a syrinx (cystic cavity). Syrinxes may extend along several spinal segments and cause focal spinal cord damage by compression, ischemia, and disruption of normal neural networks.
• Breed specificity: Genetic and developmental features particular to CKCS (cranial shape and skull base growth patterns) make this cascade much more prevalent in the breed compared with general dog populations.

These changes are progressive in many dogs: a young CKCS may have mild CM on MRI and later develop clinically significant SM.

Clinical signs — what Cavaliers typically show

CKCS with CM/SM can present with a spectrum of signs from subtle to severe. Signs are frequently bilateral and may wax and wane early in the disease.

Common and breed‑specific clinical features:

• Phantom scratching: Repeated, often violent scratching movements directed at the neck/shoulder region that do not make contact with the skin. This behavior is highly characteristic of SM in Cavaliers and is often the first sign noted by owners.
• Neck/cranial pain: Intermittent to chronic neck pain, vocalization when picked up or handled around the head/neck, reluctance to be touched on the head/neck region.
• Hyperesthesia and sensitivity to touch: Sensitivity along the neck and shoulders; dogs may snap, cry out, or avoid handling.
• Scoliosis or head tilt: Structural secondary changes such as mild scoliosis or scoliosis‑type posture (asymmetrical neck carriage) are reported in some affected Cavaliers.
• Forelimb weakness, ataxia, or proprioceptive deficits: If there is significant syrinx expansion into the cervical spinal cord, dogs may show paresis or coordination deficits.
• Sleep disturbance, decreased activity, irritability, or behavioral changes: Chronic pain can produce changes in temperament and activity that owners often interpret as “old age” unless CM/SM is considered.

Less typical but reported:

• Facial rubbing, pawing at the face, or ear complaints (may be concurrent PSOM).
• Seizures are not a typical direct result of CM/SM but should prompt evaluation for other intracranial pathology.

Important: not every CKCS with CM on MRI will have clinical signs; clinical correlation is essential.

Distinguishing CM/SM from PSOM (primary secretory otitis media)

Primary secretory otitis media (PSOM), commonly called “glue ear,” is overrepresented in CKCS and can cause head/neck pain, scratching at the ears, facial rubbing, and reduced hearing — signs that overlap with CM/SM.

Key differences and diagnostic clues:

• Location of pain: PSOM often results in localized ear discomfort, head‑tilt, or ear‑related shaking, whereas CM/SM often produces phantom scratching directed at the neck/shoulder and obvious neck pain on handling.
• Otoscopic exam and myringotomy: PSOM is diagnosed by finding a viscous, mucoid middle ear effusion on otoscopy or myringotomy (although bulla disease can be occult). A negative ear exam does not exclude PSOM if the tympanic membrane is intact and effusion is contained.
• Imaging: MRI will pick up both PSOM (fluid in tympanic bullae) and CM/SM; CT can show bulla changes. Because PSOM and CM/SM can coexist in CKCS, clinicians often image both the brain and ears during the same anesthetic.
• Treatment response: PSOM often responds to myringotomy and flushing ± glucocorticoid therapy; phantom scratching and neuropathic pain of SM will not resolve with ear‑directed treatment.

Because of the high coexistence rate in Cavaliers, a neurologic evaluation that includes otic assessment is essential.

Diagnosis: best test, grading, and what it shows in Cavaliers

• Gold standard: MRI of the brain and cervical spine with T1, T2, and ideally CSF flow sequences (cine MRI) is required. MRI identifies overcrowding at the foramen magnum, degree of cerebellar herniation, syrinx size/extent, and can show concurrent PSOM or hydrocephalus.
• When to image: any CKCS with persistent neck pain, phantom scratching, or neurologic deficits should be referred for MRI with a veterinary neurologist/neurosurgeon. Screening MRIs are also used in breeding programs.
• Typical MRI findings in CKCS:

- Reduced volume of the caudal cranial fossa and cerebellar crowding - Descent/hernia of cerebellar tissue through the foramen magnum - Syrinx(es) in the cervical spinal cord — may extend cranially or caudally - Occasionally concurrent hydrocephalus or middle ear effusion

Grading systems (commonly used in breed screening and clinical practice):

• Chiari‑like malformation: Descriptive grading focuses on presence/absence and degree of cerebellar herniation and caudal fossa crowding.
• Syrinx grading (commonly applied): maximum syrinx transverse diameter is used — examples used in BVA/KC screening: Grade 0 = no syrinx; Grade 1 = syrinx <2 mm; Grade 2 = syrinx 2–4 mm; Grade 3 = syrinx >4 mm (grading thresholds may vary slightly between protocols). Larger syrinx width correlates with higher likelihood of clinical signs.

Note: Standards and cutoffs are those used in the BVA/KC and other screening schemes; always use the grading system your neurologist/clinic follows.

Medical management — what works for Cavaliers

Medical therapy aims to control neuropathic pain, reduce secondary inflammation and cerebrospinal fluid pulsatility, and improve quality of life. In Cavaliers, treatment choice depends on clinical severity, imaging findings, and owner goals.

Commonly used medications and typical dosing (consult your neurologist; doses below are general ranges):

• Gabapentin — neuropathic pain agent:

- 10–20 mg/kg PO every 8 hours (TID) is a commonly used range in CKCS (weights often 5–8 kg). - Onset: 1–3 days for some pain relief; dose titration for effect may be needed.

• Pregabalin — alternative neuropathic agent:

- 2–4 mg/kg PO every 12 hours (BID) in dogs; some clinicians prefer for smoother pharmacokinetics.

• NSAIDs — for musculoskeletal and inflammatory pain:

- Meloxicam 0.1 mg/kg PO once daily (after load per product guidelines) or other appropriate canine NSAID at label dose. - Monitor renal function and for GI side effects; often combined with gastroprotection (omeprazole).

• Omeprazole — gastric protection if NSAIDs used chronically:

- 0.5–1 mg/kg PO once daily.

• Short courses of corticosteroids are occasionally used for marked acute inflammation but are not a long‑term solution because of side effects.
• Opioids (e.g., tramadol, buprenorphine) may be used short‑term for severe pain control. Tramadol efficacy for neuropathic pain in dogs is inconsistent.
• Acetazolamide and other CSF production modulators are used rarely and with limited evidence.

Practical points for Cavaliers:

• Neuropathic pain agents (gabapentin/pregabalin) are often the cornerstone for CKCS with phantom scratching and hyperesthesia.
• Many CKCS require combination therapy (neuropathic agent + NSAID + environmental management).
• Monitor for sedation, ataxia, GI signs; adjust doses for the small stature of CKCS.

Surgical options and outcomes in Cavaliers

Surgery is considered for CKCS with severe, refractory pain or progressive neurological deficits and when imaging correlates with clinical signs. Selection of candidates should be by a veterinary neurologist/neurosurgeon.

Main surgical approaches:

• Foramen magnum decompression (FMD) — removal of occipital bone over the foramen magnum to relieve compression and restore CSF flow. May be combined with:

- Durotomy or duraplasty (opening or expanding the dura) to reduce scar formation and improve flow. - Cranioplasty to stabilize bone removal if needed.

• Syringosubarachnoid or syringoperitoneal shunts — direct drainage of syrinx fluid; used in select, refractory cases.
• Ventriculoperitoneal shunting — for concurrent hydrocephalus causing increased intracranial pressure.

Outcomes in CKCS:

• Case series report significant and sometimes rapid reduction in pain in many surgically treated Cavaliers; subjective improvement in ~60–80% of dogs is commonly cited across studies (selection bias applies).
• MRI follow‑up may show syrinx size reduction in many dogs, but radiographic improvement does not always correlate perfectly with clinical outcome.
• Risks and complications: surgical wound infection, recurrence of obstruction due to scar tissue (arachnoiditis), CSF leak, and anesthesia risks. Re‑operation rates and long‑term recurrence vary.
• Long‑term prognosis post‑surgery is variable; some CKCS have durable pain control and improved activity, while others may have recurrence months to years later.

Decision considerations for CKCS:

• Surgery tends to be most successful in dogs with clear correlation between their clinical signs and MRI findings, and when performed by experienced neurosurgeons.
• Owners should weigh potential benefits with risks, costs, and the possibility of ongoing medical therapy after surgery.

Monitoring, follow‑up, and quality of life

• Pain scoring and patient diaries: track frequency/duration of phantom scratching, vocalization, sleep disturbance, and activity level to guide therapy adjustments.
• Re‑imaging: follow‑up MRI is often performed if clinical signs progress or to evaluate response to surgery; timing varies (3–12 months post‑op is common for surgical cases).
• Avoid exacerbating factors: Cavaliers should avoid activities that strain the neck (e.g., excessive jumping, sudden pulling on a leash) and be handled gently around the head and neck.
• Multimodal approach: combining medication, physical therapy (low‑impact), environmental modification, and behavior management often yields the best quality‑of‑life outcomes in CKCS.
• Breeding considerations: because CM/SM are heritable and prevalent in CKCS, screening breeding dogs via MRI per national kennel club/BVA guidelines is encouraged to reduce incidence in future generations.

Table: Diagnostic & treatment options at a glance for Cavalier King Charles Spaniels

| Problem/Goal | Test or intervention | What it shows/does | Breed‑specific notes | |---|---:|---|---| | Confirm CM/SM | MRI brain + cervical spine (with CSF flow sequences if possible) | Visualizes cerebellar herniation, caudal fossa crowding, syrinx size/extent, PSOM, hydrocephalus | Gold standard for CKCS; required to make surgical decisions | | Differentiate ear disease | Otoscopic exam, myringotomy, MRI/CT of bullae | Middle ear effusion diagnosis; can identify PSOM | PSOM commonly coexists in CKCS and can mimic neck pain | | Initial pain control | Gabapentin 10–20 mg/kg PO TID or pregabalin 2–4 mg/kg PO BID | Neuropathic pain reduction | Often first‑line for phantom scratching in CKCS | | Anti‑inflammatory control | NSAIDs (meloxicam per label) ± omeprazole 0.5–1 mg/kg | Reduce musculoskeletal/inflammatory pain | Use with caution, monitor labs — CKCS small size needs careful dosing | | Refractory/severe cases | Foramen magnum decompression ± duroplasty ± shunts | Restores CSF flow, may reduce syrinx and pain | Variable outcomes; best in carefully selected CKCS at specialist centers | | Long‑term monitoring | Clinical scoring, recheck exams, MRI if worsens | Tracks disease progression/response | Regular follow‑up is important due to progressive nature in many CKCS |

Prognosis — what to expect for a Cavalier

• Variable: many CKCS with mild signs respond well to medical management and can have good quality of life for months to years. Dogs with large syrinxes or progressive neurologic deficits have a less favorable prognosis without surgery.
• Surgical candidates often experience meaningful pain relief, but recurrence and the need for further treatment are possible.
• Overall life expectancy is influenced by severity at diagnosis, response to therapy, and owner willingness to pursue advanced care. Careful ongoing pain management and monitoring are central to maintaining quality of life.

Practical guidance for owners of Cavaliers

• Early recognition matters: if your Cavalier shows phantom scratching, neck pain, or sensitivity around the head/neck, seek evaluation by your primary veterinarian and consider referral to a neurologist.
• Ask for MRI: because CKCS commonly have CM/SM, MRI is the only reliable way to define the problem when symptoms suggest CM/SM.
• Consider ear evaluation at the same time: because PSOM frequently coexists and can cause similar signs, assessment/flush of the middle ears during the same anesthetic is efficient.
• Keep a symptom diary: note frequency/intensity of phantom scratching, pain episodes, and behavior changes — useful for treatment decisions and follow‑up.
• Discuss breeding: if you have a CKCS with CM/SM, consult breed clubs and your vet about screening recommendations before breeding.

Key Takeaways

• CKCS are uniquely predisposed to Chiari‑like malformation due to occipital bone hypoplasia and caudal fossa overcrowding; CM is found in >90% of breed screening MRIs.
• Syringomyelia develops when CSF flow obstruction leads to syrinx formation; reported prevalence in screened CKCS is commonly around 30–50% (often cited ≈41% in screened cohorts).
• Phantom scratching — scratching motions without skin contact — is highly suggestive of SM in Cavaliers and should prompt neurologic evaluation.
• MRI of the brain and cervical spine is the diagnostic gold standard in CKCS; grading of syrinx size helps predict clinical risk and guide management.
• Medical therapy (gabapentin/pregabalin, NSAIDs, supportive care) is the first line for many Cavaliers; surgery (foramen magnum decompression ± adjuncts) is for severe or refractory cases and can provide significant benefit in selected dogs.
• PSOM (“glue ear”) frequently coexists in CKCS and can mimic CM/SM — concurrent ear assessment is important.
• Because CM/SM in Cavaliers can be progressive, close follow‑up, owner education, and involvement of a veterinary neurologist/neurosurgeon are essential to optimize outcomes and quality of life.

If you’re worried your Cavalier may have CM/SM, contact your veterinarian promptly for a neurologic referral. Early diagnosis and a tailored management plan give the best chance for sustained comfort and quality of life in this breed.